MOVEMENTUM
LIVE

Serial Number

99006194

Owner

Primus Pharmaceuticals, Inc.

Attorney

Rebecca Dalton

Filing Date

Jan 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MOVEMENTUM Trademark

Serial Number: 99006194

MOVEMENTUM is a trademark filed by Primus Pharmaceuticals, Inc. on January 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Primus Pharmaceuticals, Inc.

7373 N. Scottsdale Road, Suite B-200
Scottsdale, AZ 85253

Entity Type: 03

Trademark Details

Filing Date

January 17, 2025

Registration Date

Not Registered

Published for Opposition

October 14, 2025

Goods & Services

Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision; Pharmaceutical preparations for the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Vitamin preparations; Pharmaceutical preparations for restoring and maintaining health and function in the presence of pain, physical discomfort, stiffness, sensitization, energy, arterial, venous, circulatory, cognitive, mental, central nervous system, autoimmune and mobility limitations; Pharmaceutical preparations for the treatment and management of pain, physical discomfort, sensitization, energy, arterial, venous, circulatory, stiffness, and mobility limitations; Nutritional Supplements; Pharmaceutical preparations for the treatment, management, and maintenance of physical function in neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Dietary supplements; Pharmaceutical preparations for the treatment, prevention, and management of neurological, musculoskeletal, fibromyalgia, cardiovascular, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments; Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision in the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Pharmaceutical preparations as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 9, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 9, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 9, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 16, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 16, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 2, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 17, 2025 MAFR
NEW APPLICATION ENTERED
Jan 17, 2025 NWAP